Thrombosis Canada/LinkedIn
Dec 6, 2025, 06:25
Dr. Jeff Weitz Unpacks the Latest ROXI-VTE Trials
Thrombosis Canada shared a new post on LinkedIn:
“New episode!
We sat down with Dr. Jeff Weitz to unpack the latest ROXI-VTE trials and what the data could mean for the future of thrombosis prevention.
If you manage patients at risk of VTE, don’t miss this conversation—full of clinical insights, context, and what’s coming next.
Episode goes live across all platforms within 24 hours, but if you can wait, listen to it here.
Title: ROXI-VTE Trials Explained: Dr. Jeff Weitz on Next-Generation Thrombosis Prevention”
Get the latest with Hemostasis Today.
-
May 10, 2026, 14:31Thomas Rocco: Humanity in the Age of AI
-
May 10, 2026, 14:03Educational Grant Opportunities for Post–Secondary Students with Inherited Bleeding Disorders – Irish Haemophilia Society
-
May 10, 2026, 13:49Mona Alfaraj: What’s Special About Inherited Macrothrombocytopenia?
-
May 10, 2026, 12:14Ana Cláudia de Souza: Presenting ÁRTEMIS-Brasil at ESOC 2026
-
May 10, 2026, 12:11Umberto Pensato: SPOTMAP Project and ESCAPE-MeVO Analysis Honored with Awards at ESOC 2026
-
May 10, 2026, 12:05Purusotham Chippala: A Comprehensive Patient and Caregiver Education Guide to Make Stroke Easier
-
May 10, 2026, 11:57Mostafa Meshref: Find Our Research Contributions at ESOC 2026
-
May 10, 2026, 11:39Ruisheng Su: Stroke Timer Is an Early Accept at MICCAI 2026
-
May 10, 2026, 11:24Ali Ahmadi: The Immune Landscape After Ischemic Stroke and How to Advance Toward Effective Therapeutic Strategies